组织芯片，组织微阵列

FDA808i-2	多器官癌及边缘器官组织组合芯片，附病理分级、TNM和临床分期，72例/72点，替代FDA808h-2
点数	72	例数	72
行数	8	列数	9
点直径(mm)	1.5	厚度(µm)	5.0
组织阵列类型	石蜡包埋	种属	人类
QA/QC	H&E and IHC confirmed
Applications	Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes	1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment.

Legend:

Smo

-Smooth muscle

Per

-Peritoneum

Car

-Cartilage

Bla

-Bladder

Lym

-Lymph node

Ret

-Retroperitoneum

Ner

-Nerve

Ski

-Skin

Rec

-Rectum

Ske

-Skeletal muscle

Cer

-Cervix

Ute

-Uterus

Pro

-Prostate

Kid

-Kidney

Liv

-Liver

Col

-Colon

Sma

-Small intestine

Sto

-Stomach

Eso

-Esophagus

Lun

-Lung

Spl

-Spleen

Bre

-Breast

Thy

-Thyroid

Tes

-Testis

Pan

-Pancreas

Ova

-Ovary

Cer

-Cerebrum

Car

-Cardiac pericardium

AT (*)

Malignant (*)

Malignant (0.0)

Malignant (I)

Malignant (IA)

Malignant (IB)

Malignant (IC)

Malignant (II)

Malignant (IIA)

Malignant (IIB)

Malignant (III)

Malignant (IIIA)

Malignant (IV)

NAT (*)

Normal (*)

TISSUE ARRAYS FDA808i-2

	1	2	3	4	5	6	7	8	9
A	UTE	UTE	CER	CER	CER	CER	SKE	SKE	SKE
B	SKI	SKI	SKI	NER	NER	NER	LUN	CAR	CAR
C	CER	CER	CER	CER	OVA	OVA	PAN	PAN	TES
D	TES	THY	THY	BRE	BRE	BRE	SPL	LUN	LUN
E	LUN	ESO	ESO	STO	SMA	SMA	COL	COL	REC
F	REC	LIV	LIV	KID	PRO	PRO	UTE	UTE	UTE
G	CER	CER	SKE	REC	SKI	SKI	NER	RET	PER
H	LYM	LYM	LYM	LYM	BLA	BLA	CAR	PER	SMO

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type	isBackUp
A1	1	45	F	Uterus	Endometrium tissue	*	*	*	Normal	N
A2	2	18	F	Uterus	Endometrium tissue	*	*	*	Normal	N
A3	3	41	F	Cervix	Adjacent normal endometrium tissue	*	*	*	NAT	N
A4	4	36	F	Cervix	Cancer adjacent cervical canals tissue	*	*	*	AT	N
A5	5	72	F	Cervix	Adjacent normal cervix tissue	*	*	*	NAT	N
A6	6	65	F	Cervix	Adjacent normal cervix tissue	*	*	*	NAT	N
A7	7	40	M	Skeletal muscle	Skeletal muscle tissue	*	*	*	Normal	N
A8	8	49	F	Skeletal muscle	Adjacent normal skeletal muscle tissue	*	*	*	NAT	N
A9	9	50	M	Skeletal muscle	Skeletal muscle tissue	*	*	*	Normal	N
B1	10	45	M	Skin	Skin tissue	*	*	*	Normal	N
B2	11	37	M	Skin	Skin tissue	*	*	*	Normal	N
B3	12	18	F	Skin	Skin tissue	*	*	*	Normal	N
B4	13	35	M	Nerve	Peripheral nerve tissue	*	*	*	Normal	N
B5	14	25	M	Nerve	Peripheral nerve tissue	*	*	*	Normal	N
B6	15	40	M	Nerve	Peripheral nerve tissue	*	*	*	Normal	N
B7	16	21	F	Lung	Lung and pleura tissue	*	*	*	Normal	N
B8	17	26	F	Cardiac pericardium	Mesothelium tissue	*	*	*	Normal	N
B9	18	19	M	Cardiac pericardium	Pericardium and mesothelium tissue	*	*	*	Normal	N
C1	19	43	M	Cerebrum	Glioblastoma	4	*	*	Malignant	N
C2	20	65	F	Cerebrum	Atypical meningioma	*	*	*	Malignant	N
C3	21	61	F	Cerebrum	Glioblastoma	4	*	*	Malignant	N
C4	22	39	F	Cerebrum	Oligodendroglioma of right parietal lobe	*	*	*	Malignant	N
C5	23	63	F	Ovary	High grade serous carcinoma	*	T2N0M0	II	Malignant	N
C6	24	29	F	Ovary	High grade serous carcinoma	*	T3N0M0	III	Malignant	N
C7	25	16	F	Pancreas	Islet cell tumor	*	*	*	Malignant	N
C8	26	64	M	Pancreas	Duct adenocarcinoma	2	T3N0M0	IIA	Malignant	N
C9	27	32	M	Testis	Seminoma	*	T1N0M0	I	Malignant	N
D1	28	30	M	Testis	Embryonal carcinoma	*	T2N0M0	IB	Malignant	N
D2	29	33	F	Thyroid	Medullary carcinoma	*	T3N0M0	I	Malignant	N
D3	30	46	F	Thyroid	Papillary carcinoma	*	T4N0M0	IV	Malignant	N
D4	31	67	F	Breast	Intraductal carcinoma with early infiltrate	*	TisN0M0	0.0	Malignant	N
D5	32	48	F	Breast	Invasive ductal carcinoma	2	T3N1M0	IIIA	Malignant	N
D6	33	58	F	Breast	Invasive ductal carcinoma	2	T2N1M0	IIB	Malignant	N
D7	34	21	M	Spleen	Diffuse B-cell lymphoma	*	*	*	Malignant	N
D8	35	61	M	Lung	Small cell undifferentiated carcinoma	*	T2N0M0	IB	Malignant	N
D9	36	66	M	Lung	Squamous cell carcinoma	3	T2N0M0	IB	Malignant	N
E1	37	42	M	Lung	Adenocarcinoma	3	T1N0M0	IA	Malignant	N
E2	38	68	M	Esophagus	Squamous cell carcinoma	2	T3N1M0	IIIA	Malignant	N
E3	39	63	M	Esophagus	Adenocarcinoma	3	T3N0M0	IIA	Malignant	N
E4	40	73	F	Stomach	Mucinous adenocarcinoma	3	T2N1M0	IIA	Malignant	N
E5	41	64	F	Small intestine	Adenocarcinoma with necrosis (sparse)	3	T4N0M0	IIB	Malignant	N
E6	42	71	F	Small intestine	Malignant interstitialoma	*	T2N0M0	I	Malignant	N
E7	43	72	F	Colon	Adenocarcinoma	1	T4N0M0	IIB	Malignant	N
E8	44	54	M	Colon	Interstitialoma	*	T2N0M0	I	Malignant	N
E9	45	36	M	Rectum	Adenocarcinoma	2	T2N0M0	I	Malignant	N
F1	46	63	F	Rectum	Malignant interstitialoma	*	T2N0M0	I	Malignant	N
F2	47	55	F	Liver	Hepatocellular carcinoma	2	T3N0M0	III	Malignant	N
F3	48	17	F	Liver	Hepatoblastoma	*	*	*	Malignant	N
F4	49	60	M	Kidney	Clear cell carcinoma	1	T2N0M0	II	Malignant	N
F5	50	80	M	Prostate	Adenocarcinoma (Gleason grade:4, gleason score:4+4)	*	T2N1M1C	IV	Malignant	N
F6	51	77	M	Prostate	Adenocarcinoma (Gleason grade:5, gleason score:5+4)	*	T2N0M0	IIA	Malignant	N
F7	52	56	F	Uterus	Lowly malignant leiomyosarcoma	*	T2BN0M0	IIB	Malignant	N
F8	53	50	F	Uterus	Endometrioid adenocarcinoma	1	T1BN0M0	IB	Malignant	N
F9	54	57	F	Uterus	Clear cell carcinoma	*	T1CN0M0	IC	Malignant	N
G1	55	36	F	Cervix	Squamous cell carcinoma	3	T1BN0M0	IB	Malignant	N
G2	56	49	F	Cervix	Invasive squamous cell carcinoma	3	T2N0M0	II	Malignant	N
G3	57	20	F	Skeletal muscle	Embryonal rhabdomyosarcom of left leg	*	T1AN0M0	IA	Malignant	N
G4	58	70	F	Rectum	Malignant melanoma	*	T4N0M0	IIB	Malignant	N
G5	59	61	M	Skin	Basal cell carcinoma of left face	*	T2N0M0	IIA	Malignant	N
G6	60	64	M	Skin	Squamous cell carcinoma with necrosis of chest wall	2	T3N0M0	IIA	Malignant	N
G7	61	21	M	Nerve	Neurofibroma of back	*	*	*	Malignant	N
G8	62	1	F	Retroperitoneum	Neuroblastoma	*	*	*	Malignant	N
G9	63	60	M	Peritoneum	Malignant mesothelioma	*	T2N0M0	II	Malignant	N
H1	64	55	M	Lymph node	Diffuse B cell lymphoma of armpit	*	*	*	Malignant	N
H2	65	50	F	Lymph node	Diffuse B cell lymphoma of right thigh	*	*	*	Malignant	N
H3	66	27	M	Lymph node	Hodgkin's lymphoma of left groin (mixed cell type)	*	*	*	Malignant	N
H4	67	36	M	Lymph node	Anaplastic large cell lymphoma of left groin	*	*	*	Malignant	N
H5	68	58	F	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	N
H6	69	62	M	Bladder	Lowly malignant leiomyosarcoma	*	T2N0M0	II	Malignant	N
H7	70	51	M	Cartilage	Well differentiated osteosarcoma of left femur	*	T2N0M0	II	Malignant	N
H8	71	48	F	Peritoneum	Highly malignant pleomorphic rhabdomyosarcoma	*	T2N0M0	II	Malignant	N
H9	72	60	F	Smooth muscle	Moderate malignant leiomyosarcoma of left buttock	*	T2BN0M0	IIB	Malignant	N
Tissue Marker